Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling - Crocs (NASDAQ:CROX), Lyft

The Nasdaq 100 closed lower by over 150 points on Friday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Crocs

The Trade: Crocs, Inc. (NASDAQ:CROX) President Michelle Poole sold a total of 4,793 shares at an average price of $119.15. The insider received over $571,086 from selling those shares.
What’s Happening: Crocs reported better-than-expected fourth-quarter financial results.
What Crocs Does: Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children.

Have a look at our premarket coverage here

Lyft

The Trade: Lyft, Inc. (NASDAQ:LYFT) President Kristin Sverchek sold a total of 12,670 at an average price of $15.64. The insider received around $198,990 from selling those shares.
What’s Happening: Lyft recently reported fourth-quarter financial results and issued guidance.
What Lyft Does: Lyft is the second-largest ride-sharing service provider in the U.S. and Canada, connecting riders and drivers over the Lyft app.

Starbucks

The Trade: Starbucks Corporation (NASDAQ:SBUX) Group President International Michael Aaron Conway sold a total of 3,250 shares at an average price of $94.03. The insider received around $305,598 from selling those shares.
What’s Happening: Starbucks said first-quarter revenue increased 8% year-over-year to $9.4 billion, which missed the consensus estimate of $9.59 billion.
What Starbucks Does: Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 38,000 stores across more than 80 countries as of the end of fiscal 2023.

Regeneron Pharmaceuticals

The Trade: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) EVP & General Mgr, Industrial Plew Daniel P Van sold a total of 10,434 shares at an average price of $942.28. The insider received around $9.8 million from selling those shares.
What’s Happening: Regeneron Pharmaceuticals reported fourth-quarter adjusted EPS of $11.86, down 6% Y/Y, beating the consensus of $10.77.
What Regeneron Pharmaceuticals Does: Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.

Check This Out: Top 5 Industrials Stocks That May Collapse This Quarter

REGNRegeneron Pharmaceuticals Inc

$676.69-%

SBUXStarbucks Corp

$105.550.06%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.